DeSimone Daniel C, Sohail Muhammad Rizwan
Division of Infectious Diseases, Department of Medicine, Mayo Clinic College of Medicine and Science, 200 1st Street Southwest, Rochester, MN, USA; Department of Cardiovascular Diseases, Mayo Clinic College of Medicine and Science, 200 1st Street Southwest, Rochester, MN, USA.
Division of Infectious Diseases, Department of Medicine, Mayo Clinic College of Medicine and Science, 200 1st Street Southwest, Rochester, MN, USA; Department of Cardiovascular Diseases, Mayo Clinic College of Medicine and Science, 200 1st Street Southwest, Rochester, MN, USA.
Card Electrophysiol Clin. 2018 Dec;10(4):601-607. doi: 10.1016/j.ccep.2018.04.002.
Cardiovascular implantable electronic devices (CIEDs) and the indications for their use have significantly risen over the past decades to include patients who are older with more medical comorbidities. Predictably, the rates of CIED infection have increased substantially. CIED infection is associated with high morbidity, mortality, and financial costs. This article discusses the appropriate management of CIED infections, which is imperative to limit the problems associated with infection.
在过去几十年中,心血管植入式电子设备(CIEDs)及其使用指征显著增加,涵盖了年龄更大、合并更多疾病的患者。不出所料,CIED感染率大幅上升。CIED感染与高发病率、死亡率及经济成本相关。本文讨论了CIED感染的恰当管理,这对于限制与感染相关的问题至关重要。